{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:00:45Z","timestamp":1790704845184,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.soncn.2026.152393","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:52:42Z","timestamp":1790689962000},"page":"152393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing Surface Contamination by Hazardous Drugs in a Comprehensive Cancer Centre in Ireland Using Surface Wipe Sampling"],"prefix":"10.1016","volume":"42","author":[{"given":"Audrey","family":"O\u2019Halloran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sessink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Zhanen","family":"Clarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1720-5673","authenticated-orcid":false,"given":"Amanda","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soncn.2026.152393_bib0001","unstructured":"World Health Organization. WHO factsheet: cancer; 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer. Accessed January 15, 2026."},{"key":"10.1016\/j.soncn.2026.152393_bib0002","series-title":"Cancer in Ireland 1994-2022: Annual statistical report of the National Cancer Registry","year":"2024"},{"key":"10.1016\/j.soncn.2026.152393_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med"},{"issue":"1","key":"10.1016\/j.soncn.2026.152393_bib0004","article-title":"Data Resource profile: the systemic anti-cancer therapy (SACT) dataset","volume":"49","author":"Bright","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.soncn.2026.152393_bib0005","series-title":"Cancer chemotherapy","author":"Amjad","year":"2026"},{"key":"10.1016\/j.soncn.2026.152393_bib0006","unstructured":"Musu T, Lindsley I The ETUI's list of hazardous medicinal products (HMPs); 2022. https:\/\/www.etui.org\/publications\/etuis-list-hazardous-medicinal-products-hmps. Accessed: 15\/01\/2026."},{"key":"10.1016\/j.soncn.2026.152393_bib0007","series-title":"Hazardous Drugs-Handling in Healthcare Settings","year":"2020"},{"key":"10.1016\/j.soncn.2026.152393_bib0008","unstructured":"Health and Safety Authority Ireland. Hazardous Medicinal Products (HMPs); 2025. https:\/\/www.hsa.ie\/eng\/your_industry\/chemicals\/legislation_enforcement\/chemical_agents_and_carcinogens\/carcinogens_mutagens_and_reprotoxic_substances\/hazardous_medicinal_products_hmps_\/. Accessed January 15, 2026."},{"issue":"2","key":"10.1016\/j.soncn.2026.152393_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/NCC.0000000000000143","article-title":"Antineoplastic drug exposure in an ambulatory setting: a pilot study","volume":"38","author":"Friese","year":"2015","journal-title":"Cancer Nurs"},{"issue":"3","key":"10.1016\/j.soncn.2026.152393_bib0010","doi-asserted-by":"crossref","first-page":"E299","DOI":"10.1188\/12.ONF.E299-E309","article-title":"Factors influencing oncology nurses' use of hazardous drug safe-handling precautions","volume":"39","author":"Polovich","year":"2012","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"10.1016\/j.soncn.2026.152393_bib0011","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3928\/00220124-20160120-03","article-title":"Chemotherapy and biotherapy: what nurses need to know when administering to nononcologic patients","volume":"47","author":"Redmond","year":"2016","journal-title":"J Contin Educ Nurs"},{"issue":"3","key":"10.1016\/j.soncn.2026.152393_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216098","article-title":"Environmental assessment of cytotoxic drugs in the Oncology Center of Cyprus","volume":"15","author":"Soteriades","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.soncn.2026.152393_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1188\/17.CJON.73-78","article-title":"Chemotherapy safe handling: limiting nursing exposure with a hazardous drug control program","volume":"21","author":"Crickman","year":"2017","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.soncn.2026.152393_bib0014","unstructured":"National Institute for Occupational Safety and Health. (2023) Managing Hazardous Drug Exposures: Information for Healthcare Settings. URL: https:\/\/archive.cdc.gov\/www_cdc_gov\/niosh\/docs\/2016-161\/default.html. Accessed August 13, 2025."},{"key":"10.1016\/j.soncn.2026.152393_bib0015","series-title":"Study Supporting the Assessment of Different Options Concerning the Protection of Workers from Exposure to Hazardous Medicinal Products, Including Cytotoxic Medicinal Products\u202f: Final Report","author":"Sand Jespersen","year":"2021"},{"issue":"12","key":"10.1016\/j.soncn.2026.152393_bib0016","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/15459624.2019.1667502","article-title":"Assessing variability of antineoplastic drugs handling practices in clinical settings","volume":"16","author":"Arnold","year":"2019","journal-title":"J Occup Environ Hyg"},{"issue":"5","key":"10.1016\/j.soncn.2026.152393_bib0017","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/1078155218773862","article-title":"Surface contamination with ten antineoplastic drugs in 83 Canadian centers","volume":"25","author":"Chauchat","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"10.1016\/j.soncn.2026.152393_bib0018","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1188\/20.ONF.263-272","article-title":"Surface contamination with antineoplastic drugs on two inpatient oncology units","volume":"47","author":"Walton","year":"2020","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.soncn.2026.152393_bib0019","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1196\/annals.1371.021","article-title":"Hazardous anticancer drugs in health care: environmental exposure assessment","volume":"1076","author":"Connor","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.soncn.2026.152393_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1188\/21.CJON.151-156","article-title":"Hazardous drug contamination: presence of bathroom contamination in an Ambulatory Cancer Center","volume":"25","author":"Eisenberg","year":"2021","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"10.1016\/j.soncn.2026.152393_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/2165079916662660","article-title":"Occupational exposure to antineoplastic agents","volume":"65","author":"Graeve","year":"2017","journal-title":"Workplace Health Saf"},{"issue":"9","key":"10.1016\/j.soncn.2026.152393_bib0022","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/15459624.2016.1165912","article-title":"Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: methodology and recommendations","volume":"13","author":"Connor","year":"2016","journal-title":"J Occup Environ Hyg"},{"key":"10.1016\/j.soncn.2026.152393_bib0023","unstructured":"Trinity St James\u2019s Cancer Institute. Trinity St. James\u2019s Cancer Institute Annual Report 2023. 2023. URL: https:\/\/www.stjames.ie\/cancer\/aboutus\/reportsandstrategies\/tsjciannualreports\/tsjciannualreport2023\/. Accessed January 15, 2026."},{"issue":"6","key":"10.1016\/j.soncn.2026.152393_bib0024","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/15459624.2025.2471397","article-title":"A scoping review of surface wipe sampling for antineoplastic drug contamination in patient care areas","volume":"22","author":"Walton","year":"2025","journal-title":"J Occup Environ Hyg"},{"key":"10.1016\/j.soncn.2026.152393_bib0025","unstructured":"Exposure Control. Cyto Wipe Kit; https:\/\/www.exposurecontrol.net\/services. Accessed August 13, 2026."},{"issue":"7","key":"10.1016\/j.soncn.2026.152393_bib0026","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1078155217704990","article-title":"Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies","volume":"24","author":"Crul","year":"2018","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"10.1016\/j.soncn.2026.152393_bib0027","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/10781552231205481","article-title":"Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling","volume":"30","author":"Sessink","year":"2024","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.soncn.2026.152393_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.heha.2024.100089","article-title":"Wipe sampling of antineoplastic drugs from workplace surfaces: a review of analytical methods and recommendations","volume":"9","author":"Vermette","year":"2024","journal-title":"Hygiene Environment Health Adv"},{"issue":"1","key":"10.1016\/j.soncn.2026.152393_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1078155216676632","article-title":"Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 48 Canadian hospitals","volume":"24","author":"Poupeau","year":"2018","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"10.1016\/j.soncn.2026.152393_bib0030","doi-asserted-by":"crossref","DOI":"10.4212\/cjhp.3671","article-title":"Canadian monitoring program for surface contamination with 11 antineoplastic drugs in 126 centres: results for 2023","volume":"78","author":"Dupr\u00e9","year":"2025","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.soncn.2026.152393_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/10781552251343180","article-title":"Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 131 centres","author":"Morel","year":"2025","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"10.1016\/j.soncn.2026.152393_bib0032","first-page":"191","article-title":"Comparing two methods of reducing hospital toilet aerosols","volume":"27","author":"Eisenberg","year":"2023","journal-title":"Clin J Oncol Nurs"},{"issue":"5","key":"10.1016\/j.soncn.2026.152393_bib0033","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1177\/10781552231190015","article-title":"Assessing floor contamination by antineoplastic agents in a Japanese medical institution specializing in cancer treatment","volume":"30","author":"Maeda","year":"2024","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"10.1016\/j.soncn.2026.152393_bib0034","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/10781552241250010","article-title":"Assessment of the surface contamination of the primary packaging of oral antineoplastic drugs and secondary packaging of chemotherapy preparations at a Swiss hospital","volume":"31","author":"Nguyen","year":"2025","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"10.1016\/j.soncn.2026.152393_bib0035","first-page":"251","article-title":"Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital","volume":"57","author":"Yoshida","year":"2013","journal-title":"Ann Occup Hyg"},{"issue":"5","key":"10.1016\/j.soncn.2026.152393_bib0036","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/21650799221140583","article-title":"The factors that influence chemotherapy exposure among nurses: an integrative review","volume":"71","author":"Abu-Alhaija","year":"2023","journal-title":"Workplace Health Saf"},{"issue":"17","key":"10.1016\/j.soncn.2026.152393_bib0037","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/ajhp\/zxab134","article-title":"Report on 2020 safe to touch consensus conference on hazardous drug surface contamination","volume":"78","author":"Gabay","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.soncn.2026.152393_bib0038","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.3390\/ijerph20064952","article-title":"Occupational exposure to antineoplastic drugs in twelve french health care setting: biological monitoring and surface contamination","volume":"20","author":"Ndaw","year":"2023","journal-title":"Int J Environ Res Public Health"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208126002731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208126002731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:52:55Z","timestamp":1790704375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208126002731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0749208126002731"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2026.152393","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing Surface Contamination by Hazardous Drugs in a Comprehensive Cancer Centre in Ireland Using Surface Wipe Sampling","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2026.152393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152393"}}